Purchase Order 75N92E21P00140

<p>The National Human Genome Research Institute awarded a $220,000 purchase order to Pacific Biosciences of California, Inc. on April 18, 2019 for a PacBio Sequel System 8M upgrade. Work is performed in Menlo Park, California, with an ultimate completion date of October 31, 2019. The order uses firm fixed-price pricing with no small business set-aside.</p>

<p>The National Human Genome Research Institute issued a purchase order to Pacific Biosciences of California, Inc. on October 8, 2020, with a ceiling value of $23,531.00 to perform high-throughput, large-scale DNA sequencing and sequence analysis. Work is performed in Menlo Park, California. The order carries firm fixed-price pricing and has an ultimate completion date of December 8, 2020.</p>

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed-price purchase order contract to Pacific Biosciences of California, Inc. to provide SEQUEL II SEQUENCING KIT 2.0 BUNDLE. The contract has a potential value of $118,381.00 and a completion date of December 31, 2022. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services for DNA/RNA sequencing systems. The company has...

<p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>

<p>The National Human Genome Research Institute issued a $13,029.68 delivery order to Illumina, Inc. on September 12, 2017, for genetic sequencing and genomic analysis equipment and supplies.</p> <p>Place of performance is North Bethesda, Maryland. The order has a firm fixed-price structure and an ultimate completion date of October 11, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a $122,145.01 delivery order to Illumina, Inc. on September 15, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of December 15, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a $149,443.06 delivery order to Illumina, Inc. on March 29, 2018, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed price and an ultimate completion date of April 28, 2018. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a $15,321.60 delivery order to Illumina, Inc. on July 18, 2019, for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 2, 2020. No set-aside was used for this award.</p>

<p>The National Human Genome Research Institute issued a $98,905.32 delivery order to Illumina, Inc. on August 22, 2019, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order is firm fixed-price with an ultimate completion date of September 2, 2020. No set-aside was used.</p>

<p>The National Institute of Child Health and Human Development awarded a purchase order to Pacific Biosciences of California, Inc. for $35,000 on April 21, 2020, with a one-year service agreement for a sequencer, completing April 22, 2021. The order is firm fixed price with no small business set-aside. Performance occurs in Bethesda, Maryland. The originating solicitation was posted March 20, 2020 with a due date of March 30, 2020.</p>